[Experts consensus for the diagnosis, treatment, and prevention of coronavirus disease 2019 in the elderly]

L J Lin1, L Zhu2, G C Shi3

  • 1Department of Geriatrics, Peking University First Hospital, Beijing 100034, China.

Insights

This expert consensus addresses the unique challenges of diagnosing, treating, and preventing coronavirus disease 2019 (COVID-19) in elderly patients, emphasizing atypical presentations and tailored multidisciplinary care strategies for this vulnerable population.

Area of Science:

  • Geriatric Medicine
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Elderly patients with COVID-19 exhibit atypical clinical presentations and higher mortality rates due to physiological aging and comorbidities.
  • Standard diagnostic and treatment protocols may be insufficient for older adults, necessitating specialized approaches.

Purpose of the Study:

  • To establish expert consensus guidelines for the diagnosis, treatment, and prevention of COVID-19 specifically in the elderly population.
  • To highlight key considerations for managing COVID-19 in older adults, improving clinical outcomes.

Main Methods:

  • Development of an expert consensus by the Expert Committee of Geriatric Respiratory and Critical Care Medicine, China Society of Geriatrics.
  • Focus on clinical characteristics, diagnostic challenges, and therapeutic strategies pertinent to elderly COVID-19 patients.

Main Results:

  • Diagnosis requires emphasis on atypical presentations and recognition of underlying disease complications in the elderly.
  • Treatment necessitates a multidisciplinary team approach, considering multiple systemic functions.
  • Prevention strategies should integrate acute and chronic disease management, both in and out of hospital settings.

Conclusions:

  • Tailored diagnostic criteria are crucial for identifying COVID-19 in elderly patients with non-specific symptoms.
  • Multidisciplinary and holistic treatment strategies are essential for managing COVID-19 complications in older adults.
  • Integrated healthcare models are recommended for effective prevention and management of COVID-19 in the elderly population.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.0K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
170
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
522
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
132
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
668